Spinal performance and functional impairment in postmenopausal women with osteoporosis and osteopenia without vertebral fracture

被引:25
|
作者
Tsauo, JY
Chien, MY
Yang, RS
机构
[1] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Orthoped, Taipei 10764, Taiwan
关键词
functional impairment; osteopenia; osteoporosis; postmenopausal women; spinal performance;
D O I
10.1007/s001980200054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have paid much attention to the impact on functional impairment or quality of life from vertebral fractures secondary to osteoporosis, but little research has addressed the function of osteoporotic women without fractures. The purposes of this study were: (1) to describe spinal performance and functional impairment in postmenopausal women with osteoporosis and osteopenia without vertebral fracture, and (2) to investigate the relationship between them. Thirty postmenopausal women diagnosed as having osteoporosis or osteopenia were recruited who fulfilled the following criteria: (1) menopause for at least 6 months; (2) no vertebral fracture; (3) no medication that would interfere with calcium intake. Measurements included assessment of functional impairment and spinal performance including trunk extension/flexion isokinetic strength, spinal range of motion (ROM) and movement velocity in three planes (sagittal, frontal and transverse). The results showed that spinal ROM and velocity were significantly reduced in the osteoporosis group compared with the osteopenia group (p < 0.05), but no significant difference in trunk strength was shown. Functional impairment level showed a slight difference between the two groups (p = 0.042). There was a significant correlation between spinal ROM and motion velocity with bone mineral density; however, functional impairment correlated with motion velocity only in the transverse plane (trunk rotation) (p < 0.05). Spinal strength did not show any correlation with other parameters. It was concluded that spinal motion performance declined and functional impairment increased in relation to the severity of bone mineral loss in postmenopausal women without vertebral fracture, but their physical performance was not correlated with functional impairments.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [1] Spinal Performance and Functional Impairment in Postmenopausal Women with Osteoporosis and Osteopenia without Vertebral Fracture
    J. Y. Tsauo
    M. Y. Chien
    R. S. Yang
    [J]. Osteoporosis International, 2002, 13 : 456 - 460
  • [2] Osteopenia and osteoporosis in postmenopausal women
    Çeliktas, M
    Kozanoglu, E
    Aikimbaev, KS
    Soyupak, S
    Binokay, F
    [J]. ACTA RADIOLOGICA, 2002, 43 (06) : 609 - 614
  • [3] Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia
    Ness, J
    Aronow, WS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10): : 1427 - 1428
  • [4] Sarcopenia, Osteopenia and Functional Performance in Postmenopausal Women
    Chen, Zhaojing
    Sharma-Ghimire, Pragya
    Kim, Daeyeol
    Cavazos, Charity
    Bemben, Michael G.
    Bemben, Debra A.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (05): : 144 - 145
  • [5] Evaluation of quality of life and incidence of vertebral fracture in postmenopausal women with osteopenia
    Mariano, G. Pagano
    Caminiti, M.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S182 - S182
  • [6] EFFECTS OF FLUORIDE TREATMENT IN THE PREVENTION OF OSTEOPENIA (IN THE ABSENCE OF FRACTURE OSTEOPOROSIS) IN POSTMENOPAUSAL WOMEN
    GOLDBERG, D
    AWADA, H
    MAALEM, Z
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S317 - S317
  • [7] Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
    Kanis, JA
    Johnell, O
    Black, DM
    Downs, RW
    Sarkar, S
    Fuerst, T
    Secrest, RJ
    Pavo, I
    [J]. BONE, 2003, 33 (03) : 293 - 300
  • [8] Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Ortolani, S
    Badurski, J
    Kaufman, JM
    Spector, T
    Diez-Perez, A
    Seeman, E
    Lemmel, E
    Balogh, A
    Pors-Nielsen, S
    Phenekos, C
    Rizzoli, R
    Slosman, D
    Tupinon-Mathieu, I
    Reginster, JY
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [9] The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Seeman, E
    Ortolani, S
    Badurski, JE
    Spector, TD
    Cannata, J
    Balogh, A
    Lemmel, EM
    Pors-Nielsen, S
    Rizzoli, R
    Genant, HK
    Reginster, JY
    Graham, J
    Ng, KW
    Prince, R
    Prins, J
    Seeman, E
    Wark, J
    Reginster, JY
    Devogelaer, JP
    Kaufman, JM
    Raeman, F
    Ziekenhuis, JP
    Walravens, M
    Pors-Nielsen, S
    Beck-Nielsen, H
    Charles, P
    Sorensen, OH
    Meunier, PJ
    Aquino, JP
    Benhamou, C
    Blotman, F
    Bonidan, O
    Bourgeois, P
    Dehais, J
    Fardellone, P
    Kahan, A
    Kuntz, JL
    Marcelli, C
    Prost, A
    Vellas, B
    Weryha, G
    Lemmel, EM
    Felsenberg, D
    Hensen, J
    Kruse, HP
    Schmidt, W
    Semler, J
    Stucki, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05): : 459 - 468
  • [10] Prevalence of vertebral fracture in postmenopausal women with lumbar osteopenia using MorphoXpressSR (OSTEOXPRESS Study)
    Luis Arboleya
    Manuel Díaz-Curiel
    Luis del Río
    Josep Blanch
    Adolfo Díez-Pérez
    Nuria Guañabens
    José Manuel Quesada
    Manuel Sosa
    Carlos Gómez
    Manuel Muñoz-Torres
    Esther Ramírez
    Josep Combalia
    [J]. Aging Clinical and Experimental Research, 2010, 22 : 419 - 426